# Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

> **NCT01006876** · PHASE3 · COMPLETED · sponsor: **Texas Cardiac Arrhythmia Research Foundation** · enrollment: 1584 (actual)

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** Coumadin
- **DRUG:** Coumadin
- **DRUG:** Coumadin

## Key facts

- **NCT ID:** NCT01006876
- **Lead sponsor:** Texas Cardiac Arrhythmia Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-03
- **Final completion:** 2014-04
- **Target enrollment:** 1584 (ACTUAL)
- **Last updated:** 2015-05-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01006876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01006876, "Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01006876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*